Literature DB >> 2153685

Endothelial cell-associated platelet-activating factor: a novel mechanism for signaling intercellular adhesion.

G A Zimmerman1, T M McIntyre, M Mehra, S M Prescott.   

Abstract

The binding of neutrophils (polymorphonuclear leukocytes [PMNs]) to endothelial cells (ECs) presents special requirements in the regulation of intercellular adhesion. ECs that are stimulated by certain agonists, including thrombin and cytokines (tumor necrosis factor alpha, interleukin-1), generate molecular signals that induce the adhesion of PMNs (endothelial cell-dependent neutrophil adhesion). Our experiments demonstrate that the mechanism of binding induced by thrombin is distinct from that induced by the cytokines based on the time courses, the requirement for protein synthesis, and differential binding of HL60 promyelocytic leukemia cells to ECs activated by the two classes of agonists. The rapid EC-dependent PMN adhesion (initiated in minutes) that occurs when the ECs are stimulated by thrombin is temporally coupled with the accumulation of platelet-activating factor, a biologically active phosphoglyceride that remains associated with ECs and that activates PMNs by binding to a cell surface receptor. A portion of the newly synthesized platelet-activating factor (PAF) is on the EC surface, as demonstrated by experiments in which the rate of hydrolysis of PAF synthesized by activated ECs was accelerated by extracellular PAF acetylhydrolase. When ECs were treated with exogenous PAF they became adhesive for PMNs; the PMN binding was prevented by incubating the ECs with PAF acetylhydrolase or by treating the PMNs with competitive PAF receptor antagonists. Thus PAF associated with the EC plasma membrane induces PMN binding, an observation supported by experiments in which PAF in model membranes (liposomes) stimulated rapid PMN adhesion to ECs and to cell-free surfaces. In addition, competitive antagonists of the PAF receptor inhibited the binding of PMNs to ECs activated by thrombin and other rapidly acting agonists, but not to ECs activated by tumor necrosis factor alpha, indicating that PAF that is endogenously synthesized by ECs can mediate neutrophil adhesion. These experiments demonstrate a novel mechanism by which a cell-associated phospholipid, PAF, can serve as a signal for an intercellular adhesive event.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2153685      PMCID: PMC2116010          DOI: 10.1083/jcb.110.2.529

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  65 in total

1.  Neutrophil adherence to human endothelium in vitro occurs by CDw18 (Mo1, MAC-1/LFA-1/GP 150,95) glycoprotein-dependent and -independent mechanisms.

Authors:  G A Zimmerman; T M McIntyre
Journal:  J Clin Invest       Date:  1988-02       Impact factor: 14.808

2.  (+/-)-trans-2-(3-Methoxy-5-methylsulfonyl-4-propoxyphenyl)-5-(3,4,5- trimethoxyphenyl)tetrahydrofuran (L-659,989), a novel, potent PAF receptor antagonist.

Authors:  M M Ponpipom; S B Hwang; T W Doebber; J J Acton; A W Alberts; T Biftu; D R Brooker; R L Bugianesi; J C Chabala; N L Gamble
Journal:  Biochem Biophys Res Commun       Date:  1988-02-15       Impact factor: 3.575

3.  Monoclonal antibody-defined functional epitopes on the adhesion-promoting glycoprotein complex (CDw18) of human neutrophils.

Authors:  W J Wallis; D D Hickstein; B R Schwartz; C H June; H D Ochs; P G Beatty; S J Klebanoff; J M Harlan
Journal:  Blood       Date:  1986-04       Impact factor: 22.113

4.  Chemotactic response to human C3a and C5a anaphylatoxins. I. Evaluation of C3a and C5a leukotaxis in vitro and under stimulated in vivo conditions.

Authors:  H N Fernandez; P M Henson; A Otani; T E Hugli
Journal:  J Immunol       Date:  1978-01       Impact factor: 5.422

5.  Characteristics of human mononuclear phagocytes.

Authors:  R van Furth; J A Raeburn; T L van Zwet
Journal:  Blood       Date:  1979-08       Impact factor: 22.113

6.  Contributions of the Mac-1 glycoprotein family to adherence-dependent granulocyte functions: structure-function assessments employing subunit-specific monoclonal antibodies.

Authors:  D C Anderson; L J Miller; F C Schmalstieg; R Rothlein; T A Springer
Journal:  J Immunol       Date:  1986-07-01       Impact factor: 5.422

7.  Metabolism of platelet activating factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) and 1-alkyl-2-acetyl-sn-glycerol by human endothelial cells.

Authors:  M L Blank; A A Spector; T L Kaduce; T C Lee; F Snyder
Journal:  Biochim Biophys Acta       Date:  1986-05-21

8.  Intracellular localization of platelet-activating factor synthesis in human neutrophils.

Authors:  F Mollinedo; J Gómez-Cambronero; E Cano; M Sánchez-Crespo
Journal:  Biochem Biophys Res Commun       Date:  1988-08-15       Impact factor: 3.575

9.  Leukotrienes C4 and D4 stimulate human endothelial cells to synthesize platelet-activating factor and bind neutrophils.

Authors:  T M McIntyre; G A Zimmerman; S M Prescott
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

10.  Disialogangliosides GD2 and GD3 are involved in the attachment of human melanoma and neuroblastoma cells to extracellular matrix proteins.

Authors:  D A Cheresh; M D Pierschbacher; M A Herzig; K Mujoo
Journal:  J Cell Biol       Date:  1986-03       Impact factor: 10.539

View more
  62 in total

Review 1.  PAF. A review of its effects, antagonists and possible future clinical implications (Part II).

Authors:  M Koltai; D Hosford; P Guinot; A Esanu; P Braquet
Journal:  Drugs       Date:  1991-08       Impact factor: 9.546

2.  Oncostatin M is a proinflammatory mediator. In vivo effects correlate with endothelial cell expression of inflammatory cytokines and adhesion molecules.

Authors:  V Modur; M J Feldhaus; A S Weyrich; D L Jicha; S M Prescott; G A Zimmerman; T M McIntyre
Journal:  J Clin Invest       Date:  1997-07-01       Impact factor: 14.808

3.  Calcium-dependent biosynthesis of platelet-activating factor by submandibular gland cells.

Authors:  T Dohi; K Morita; S Kitayama; A Tsujimoto
Journal:  Biochem J       Date:  1991-05-15       Impact factor: 3.857

4.  PGF(2alpha), a prostanoid released by endothelial cells activated by hypoxia, is a chemoattractant candidate for neutrophil recruitment.

Authors:  T Arnould; R Thibaut-Vercruyssen; N Bouaziz; M Dieu; J Remacle; C Michiels
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

Review 5.  PMN adhesion and extravasation as a paradigm for tumor cell dissemination.

Authors:  C W Smith; D C Anderson
Journal:  Cancer Metastasis Rev       Date:  1991-05       Impact factor: 9.264

6.  Inflammatory roles of P-selectin.

Authors:  D E Lorant; M K Topham; R E Whatley; R P McEver; T M McIntyre; S M Prescott; G A Zimmerman
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

7.  Interaction of platelet-activating factor, spleen and atrial natriuretic peptide in plasma volume regulation during endotoxaemia in rats.

Authors:  X W Qu; R A Rozenfeld; W Huang; S E Crawford; F Gonzalez-Crussi; W Hsueh
Journal:  J Physiol       Date:  1998-10-01       Impact factor: 5.182

8.  Activation of polymorphonuclear leukocytes reduces their adhesion to P-selectin and causes redistribution of ligands for P-selectin on their surfaces.

Authors:  D E Lorant; R P McEver; T M McIntyre; K L Moore; S M Prescott; G A Zimmerman
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

9.  Oxidatively modified LDL contains phospholipids with platelet-activating factor-like activity and stimulates the growth of smooth muscle cells.

Authors:  J M Heery; M Kozak; D M Stafforini; D A Jones; G A Zimmerman; T M McIntyre; S M Prescott
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

10.  Effects of protein tyrosine kinase inhibitors on cytokine-induced adhesion molecule expression by human umbilical vein endothelial cells.

Authors:  M J May; C P Wheeler-Jones; J D Pearson
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.